08045800513
Send Inquiry
Send InquiryRabeprazole 20 mg
MOQ : 15-30 Boxes
Rabeprazole 20 mg Specification
- Drug Type
- General Medicines
- Ingredients
- Control hyper-acidity accompanied with reflux or vomiting Sensation
- Physical Form
- Tablets
- Function
- Treat Gastric Issues
- Recommended For
- Acidity,GERD
- Dosage
- 20 mg once daily
Rabeprazole 20 mg Trade Information
- Minimum Order Quantity
- 15-30 Boxes
- Supply Ability
- 100000 Boxes Per Month
- Delivery Time
- 4 Week
- Packaging Details
- Alu-Alu,10*10
- Main Domestic Market
- All India
- Certifications
- WHO-GMP
About Rabeprazole 20 mg
Rabeprazole 20 mg tablets are effective general medicines designed to alleviate gastric issues. These tablets contain 20 mg of Rabeprazole as the active ingredient, which works by reducing excess stomach acid production. Recommended for conditions such as acidity and Gastroesophageal Reflux Disease (GERD), they provide relief from persistent heartburn and promote optimal digestive health. The tablets are easy to administer, with a simple dosage of 20 mg once daily, offering a convenient treatment routine. They are manufactured with quality standards, emphasizing their reliability in managing gastric-related disorders effectively. Ideal for individuals experiencing frequent acid reflux, Rabeprazole 20 mg tablets ensure consistent and noticeable relief.
FAQs of Rabeprazole 20 mg:
Q: What is the function of Rabeprazole 20 mg tablets?
A: Rabeprazole 20 mg tablets are used to treat gastric issues, including acidity and Gastroesophageal Reflux Disease (GERD).Q: How should Rabeprazole 20 mg tablets be taken?
A: The recommended dosage is 20 mg once daily or as directed by a healthcare professional.Q: What conditions are Rabeprazole 20 mg tablets recommended for?
A: They are recommended for treating acidity and GERD.Q: What is the main ingredient in Rabeprazole 20 mg tablets?
A: The active ingredient in the tablets is Rabeprazole 20 mg.Q: Who manufactures/supports supply/export of Rabeprazole 20 mg tablets?
A: These tablets are manufactured, supplied, and exported by businesses specializing in pharmaceutical products.
Tell us about your requirement
Price:
Quantity
Select Unit
- 50
- 100
- 200
- 250
- 500
- 1000+
Additional detail
Mobile number
Email
More Products in Gastrointestinal Drugs Category
Pancreatin Bile Constituents 25 mg And Dimethicone
Price Range 10.00 - 80.00 INR
Minimum Order Quantity : 1530 Boxes
Drug Type : Specific Drug
Recommended For : Indigestion,Deficiency in Pancreas Secretions, Flatulence, Chronic Pancreatitis, Cystic Fibrosis
Function : Treat Gastric Issues
Ingredients : Control hyperacidity accompanied with reflux or vomiting Sensation
Rabeprazole 20 mg & Levosulpiride 75 mg Capsule
Price Range 10.00 - 80.00 INR
Minimum Order Quantity : 500
Drug Type : General Medicines
Recommended For : GERD,Dyspepsia,irritable bowel Syndrome
Function : Treat Gastric Issues
Ingredients : Rabeprazole 20 mg & Levosulpiride 75 mg Capsule
Esomeprazole Magnesium 40 Mg
Price Range 10.00 - 80.00 INR
Minimum Order Quantity : 1530 Boxes
Drug Type : General Medicines
Recommended For : Gastric & Duodenal Ulcers, Stomal Ulcers, Gastric Mucosal Lesions, Preanesthesia medication
Function : Treat Gastric Issues
Ingredients : Control hyperacidity accompanied with reflux or vomiting Sensation
Silymarin,L-Omithine L-Aspartate,Thiamine Mononitrate,Vit. B2,Vit. B6,Niacinamide,Cal. Panto,Vit B12
Price Range 10.00 - 80.00 INR
Minimum Order Quantity : 1530 Boxes
Drug Type : Specific Drug
Recommended For : Liver Protection
Function : Treat Gastric Issues
Ingredients : Control hyperacidity accompanied with reflux or vomiting Sensation
Contact Details
- Plot No. 364, Industrial Area, Phase-1,Chandigarh - 160002, India
- Phone : 08045800513
GST : 04AAHCS5485R1ZJ
- Mr Sanjeev Kumar Sethi (Managing Director)
- Mobile : 08045800513
- cmd@solitairegroup.in
- Mobile :+919815777744
SOLITAIRE PHARMACIA PVT. LTD.
All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Private Limited.
Developed and Managed by Infocom Network Private Limited.
